公开(公告)号：US20090312688A1

公开(公告)日：2009-12-17

申请号：US12355521

申请日：2009-01-16

Applicant: Vilambi NRK Reddy ,  Preston Keusch

Inventor： Vilambi NRK Reddy ,  Preston Keusch

IPC: A61N1/30 ,  A61M19/00

CPC classification number: A61N1/0448 ,  A61K9/0009 ,  A61N1/044 ,  A61N1/325 ,  A61N1/36021

Abstract: A shelf-stable electrically assisted transdermal drug delivery system for highly effective electrotransport of an anesthetic and a vasoconstrictor producing clinically acceptable dermal anesthesia and sensation is provided. In certain embodiments the anesthetic includes lidocaine and the vasoconstrictor includes epinephrine. Medicament delivery is affected to provide dermal anesthesia with little or no sensation during delivery, as measured by a variety of indicator tests. Methods of producing dermal anesthesia in patients are also provided.

Abstract translation: 提供了一种用于产生临床可接受的皮肤麻醉和感觉的麻醉剂和血管收缩剂的高效电运输的稳定的电辅助透皮药物递送系统。 在某些实施方案中，麻醉剂包括利多卡因，血管收缩剂包括肾上腺素。 如通过各种指标测试所测量，药物输送受影响以在输送期间提供很少或没有感觉的皮肤麻醉。 还提供了在患者体内产生真皮麻醉的方法。

公开(公告)号：US20050228335A1

公开(公告)日：2005-10-13

申请号：US10820346

申请日：2004-04-07

Applicant: Vilambi Reddy ,  Preston Keusch ,  Robert Strowe ,  Jeffrey Kapec ,  Kazuna Tanaka

Inventor： Vilambi Reddy ,  Preston Keusch ,  Robert Strowe ,  Jeffrey Kapec ,  Kazuna Tanaka

IPC: A61N1/30

CPC classification number: A61N1/0448 ,  A61N1/044

Abstract: Provided are various embodiments of integrated electrode devices, assemblies and systems structured for use in association with electrically assisted delivery devices configured for delivery of a composition to a membrane. The integrated electrode devices, assemblies and systems include one or more of a variety of structural, physical, mechanical, electrical and electromechanical enhancements.

Abstract translation: 提供了集成电极装置，组件和系统的各种实施例，其被构造为与被配置为将组合物递送到膜的电辅助输送装置相关联地使用。 集成电极装置，组件和系统包括各种结构，物理，机械，电和机电增强中的一种或多种。

公开(公告)号：US06387325B1

公开(公告)日：2002-05-14

申请号：US09414803

申请日：1999-10-08

Applicant: Preston Keusch ,  Stephen C. Wardlaw

Inventor： Preston Keusch ,  Stephen C. Wardlaw

IPC: G01N3300

CPC classification number: G01N1/4077 ,  G01N1/38 ,  G01N15/1456 ,  G01N2001/302 ,  G01N2015/008 ,  G01N2015/0084 ,  G01N2015/1486 ,  G02B21/34

Abstract: Formed constituents in an aqueous based fluid biologic material sample are separated from the aqueous constituent of the sample, and are concentrated in an examining instrument's focal plane where they can be examined under magnification. Examples of fluids that can be analyzed in this fashion include urine; cerebrospinal fluid; pleural fluid; ascites; fluids aspirated from cysts such as thyroid and breast cysts; cytologic specimens which have been placed in an aqueous fluid; platelet-rich plasma; and the like. The sample is placed in a chamber having a layer of a hydrophilic hydrogel covering a surface of the chamber. An opposite surface of the chamber is transparent, and may be formed by a microscope slide cover slip, or the like. The volume of hydrogel in the chamber is sufficient so that, when the hydrogel absorbs essentially all of the aqueous fraction of the sample, the hydrogel will expand and fill the chamber. The capture surface of the expanded hydrogel is preferably planar, and any formed constituents in the sample will be captured on the capture surface of the hydrogel layer, and will not be absorbed into the hydrogel. Formed constituents, such as: cells; bacteria; crystals; protozoa; ova; parasites; and the like, can be differentially highlighted by use of labeled antibodies, selective stains, or the like, so as to enable optical examination and differentiation of various formed constituents which may be in the sample. Formed constituents may be harvested from the capture surface of the expanded hydrogel layer for more detailed examination and analysis. The capture surface of the hydrogel may be provided with a plurality of beads for use in locating the capture surface with an optical scanning instrument, and for re-establishing previously scanned fields of view.

Abstract translation: 将含水基流体生物材料样品中的成分与样品的水性成分分离，并浓缩在检查仪的焦平面上，在此可以在放大倍数下进行检查。 可以以这种方式分析的流体的实例包括尿液; 脑脊液 胸膜液 腹水; 从囊肿如甲状腺和乳腺囊肿吸出的液体; 已经置于水性液体中的细胞学标本; 血小板富集血浆 等等。 将样品放置在具有覆盖室的表面的亲水性水凝胶层的室中。 室的相对表面是透明的，并且可以由显微镜滑盖盖等形成。 腔室中的水凝胶的体积是足够的，使得当水凝胶基本上吸收样品的所有含水部分时，水凝胶将膨胀并填充室。 膨胀的水凝胶的捕获表面优选是平面的，并且样品中的任何形成的成分将被捕获在水凝胶层的捕获表面上，并且不会被吸收到水凝胶中。 形成成分，如：细胞; 菌; 晶体 原生动物 奥娃 寄生虫 可以通过使用标记的抗体，选择性污渍等差异地突出显示，以便能够对可能在样品中的各种形成的成分进行光学检查和分化。 可以从膨胀的水凝胶层的捕获表面收获成形成分，以进行更详细的检查和分析。 水凝胶的捕获表面可以设置有多个珠子，用于使用光学扫描仪器来定位捕获表面，并且用于重建先前扫描的视场。

公开(公告)号：US20070078372A1

公开(公告)日：2007-04-05

申请号：US11537141

申请日：2006-09-29

Applicant: Vilambi Reddy ,  Preston Keusch

Inventor： Vilambi Reddy ,  Preston Keusch

IPC: A61N1/30

CPC classification number: A61N1/0448 ,  A61K9/0009 ,  A61N1/044 ,  A61N1/325 ,  A61N1/36021

Abstract: A shelf-stable electrically assisted transdermal drug delivery system for highly effective electrotransport of an anesthetic and a vasoconstrictor producing clinically acceptable dermal anesthesia and sensation is provided. In certain embodiments the anesthetic includes lidocaine and the vasoconstrictor includes epinephrine. Medicament delivery is affected to provide dermal anesthesia with little or no sensation during delivery, as measured by a variety of indicator tests. Methods of producing dermal anesthesia in patients are also provided.

Abstract translation: 提供了一种用于产生临床可接受的皮肤麻醉和感觉的麻醉剂和血管收缩剂的高效电运输的稳定的电辅助透皮药物递送系统。 在某些实施方案中，麻醉剂包括利多卡因，血管收缩剂包括肾上腺素。 如通过各种指标测试所测量，药物输送受影响以在输送期间提供很少或没有感觉的皮肤麻醉。 还提供了在患者体内产生真皮麻醉的方法。

公开(公告)号：US20050159700A1

公开(公告)日：2005-07-21

申请号：US11039520

申请日：2005-01-19

Applicant: Preston Keusch ,  Nrk Vilambi ,  Bruce Eliash

Inventor： Preston Keusch ,  Nrk Vilambi ,  Bruce Eliash

IPC: A61N1/30 ,  A61B17/20

CPC classification number: A61N1/0448 ,  A61N1/0436 ,  A61N1/044

Abstract: A reservoir electrode assembly of the present invention for an iontophoretic drug delivery device includes an electrode and a hydrophilic reservoir situated in electrically conductive relation to the electrode. The hydrophilic reservoir is formed from a bibulous hydrophilic cross-linked polymeric material having a first surface and a second surface that is adhesively adherent to the electrode. The first surface of the polymeric material is releasably adhesively adherent when applied to an area of a patient's skin. The polymeric material has a cohesive strength forms an adhesive bond with a bond strength between the second surface of the polymeric material to the electrode that is greater than the cohesive strength of the polymeric material. Additionally, an adhesive bond strength of the first surface of the polymeric material to the applied area of the patient is less than the cohesive strength of the polymeric material so that upon removal of the reservoir assembly of the invention from the applied area of the patient, substantially no polymeric material remains on the applied area and the hydrophilic reservoir remains substantially intact and adhesively adherent to the electrode.

公开(公告)号：US20050159699A1

公开(公告)日：2005-07-21

申请号：US11039519

申请日：2005-01-19

Applicant: Preston Keusch ,  Nrk Vilambi ,  Bruce Eliash

Inventor： Preston Keusch ,  Nrk Vilambi ,  Bruce Eliash

IPC: A61N1/30 ,  A61B17/20

CPC classification number: A61N1/0448 ,  A61N1/0436 ,  A61N1/044

Abstract: A reservoir electrode assembly of the present invention for an iontophoretic drug delivery device includes an electrode and a hydrophilic reservoir situated in electrically conductive relation to the electrode. The hydrophilic reservoir is formed from a bibulous hydrophilic cross-linked polymeric material having a first surface and a second surface that is adhesively adherent to the electrode. The first surface of the polymeric material is releasably adhesively adherent when applied to an area of a patient's skin. The polymeric material has a cohesive strength forms an adhesive bond with a bond strength between the second surface of the polymeric material to the electrode that is greater than the cohesive strength of the polymeric material. Additionally, an adhesive bond strength of the first surface of the polymeric material to the applied area of the patient is less than the cohesive strength of the polymeric material so that upon removal of the reservoir assembly of the invention from the applied area of the patient, substantially no polymeric material remains on the applied area and the hydrophilic reservoir remains substantially intact and adhesively adherent to the electrode.

公开(公告)号：US20100191216A1

公开(公告)日：2010-07-29

申请号：US12492361

申请日：2009-06-26

Applicant: Preston Keusch ,  Vilambi Nrk Reddy ,  Richard Greene ,  George M. Baskinger ,  Ashutosh Sharma

Inventor： Preston Keusch ,  Vilambi Nrk Reddy ,  Richard Greene ,  George M. Baskinger ,  Ashutosh Sharma

IPC: A61N1/30

CPC classification number: A61N1/30 ,  A61N1/044 ,  A61N1/0448

Abstract: The use of an iontophoresis electrode assembly for delivery of a drug formulation is described. The drug formulation includes an anaesthetic and a vasoconstrictor. It is administered to a patient prior to a procedure to produce clinically acceptable depth and duration of dermal anaesthesia at the portion of skin to subject to a painful procedure or to reduce or eliminate pain. The procedure is one selected from the group consisting of venipuncture, IV cannulation, needle aspirations, body piercings, blood donations, electrolysis, tattoo removal, tattoo application, injections, dermabrasion, skin peeling, high velocity particle ablation, pace maker implantation, pace maker replacement, epidural puncture, lumbar puncture, regional nerve blocks, skin harvesting, small skin incisions, skin biopsies, circumcisions or excisions. The iontophoresis electrode assembly may also be used to reduce or temporarily eliminate neuropathic pain.

Abstract translation: 描述了用于递送药物制剂的离子电渗电极组件的使用。 药物制剂包括麻醉剂和血管收缩剂。 在手术部分之前产生临床上可接受的皮肤麻醉深度和持续时间的患者施用于患者，以忍受痛苦的过程或减轻或消除疼痛。 该方法选自静脉穿刺，IV插管，针吸，身体穿刺，献血，电解，纹身去除，纹身应用，注射，皮肤磨皮，皮肤剥离，高速颗粒消融，起搏器植入，起搏器 替代，硬膜外穿刺，腰椎穿刺，局部神经阻滞，皮肤收获，小皮肤切口，皮肤活检，切割或切除。 离子电渗电极组件也可用于减少或暂时消除神经性疼痛。

公开(公告)号：US07252856B2

公开(公告)日：2007-08-07

申请号：US10625156

申请日：2003-07-23

Applicant: Richmond R. Cohen ,  Preston Keusch

Inventor： Richmond R. Cohen ,  Preston Keusch

IPC: B05D7/22 ,  B05D3/06 ,  A61B5/00 ,  B65D81/00

CPC classification number: A61L33/0064 ,  A61B5/15003 ,  A61B5/150213 ,  A61B5/150244 ,  A61B5/150274 ,  A61B5/150389 ,  A61B5/150503 ,  A61B5/153 ,  A61L31/145

Abstract: A process for fabricating a water-swellable porous plastic plug is provided, the process including the steps of: providing a porous substrate having a plurality of passageways therethrough, disposing into the passageways a hydrophilic polymer, irradiating the substrate to induce cross-linking of the hydrophilic polymer, such that the polymer forms a hydrogel coating on the walls of the passageways.

Abstract translation: 提供了一种制造水溶胀性多孔塑料塞的方法，该方法包括以下步骤：提供具有多个通道的多孔基材，在通道中设置亲水性聚合物，照射基材以引起交联 亲水性聚合物，使得聚合物在通道的壁上形成水凝胶涂层。

公开(公告)号：US20070093743A1

公开(公告)日：2007-04-26

申请号：US11535608

申请日：2006-09-27

Applicant: Preston Keusch ,  Vilambi Reddy ,  Ashutosh Sharma ,  George Baskinger

Inventor： Preston Keusch ,  Vilambi Reddy ,  Ashutosh Sharma ,  George Baskinger

IPC: A61N1/30

CPC classification number: A61N1/30 ,  A61N1/0436 ,  A61N1/044 ,  A61N1/0448

Abstract: An electrically assisted transdermal drug delivery system for highly effective electrotransport of an anesthetic and a vasoconstrictor producing clinically acceptable depth and duration of dermal anesthesia at a treatment site. In certain embodiments, the anesthetic comprises lidocaine and the vasoconstrictor comprises epinephrine.

Abstract translation: 用于麻醉剂和血管收缩剂的高效电运输的电辅助透皮药物递送系统，其在治疗部位产生临床可接受的皮肤麻醉深度和持续时间。 在某些实施方案中，麻醉剂包含利多卡因，血管收缩剂包含肾上腺素。

公开(公告)号：US20050159698A1

公开(公告)日：2005-07-21

申请号：US11039514

申请日：2005-01-19

Applicant: Preston Keusch ,  Nrk Vilambi ,  Bruce Eliash

Inventor： Preston Keusch ,  Nrk Vilambi ,  Bruce Eliash

IPC: A61N1/30 ,  A61B17/20

CPC classification number: A61N1/0448 ,  A61N1/0436 ,  A61N1/044

Abstract: A reservoir electrode assembly of the present invention for an iontophoretic drug delivery device includes an electrode and a hydrophilic reservoir situated in electrically conductive relation to the electrode. The hydrophilic reservoir is formed from a bibulous hydrophilic crosslinked polymeric material having a first surface and a second surface that is adhesively adherent to the electrode. The first surface of the polymeric material is releasably adhesively adherent when applied to an area of a patient's skin. The polymeric material has a cohesive strength forms an adhesive bond with a bond strength between the second surface of the polymeric material to the electrode that is greater than the cohesive strength of the polymeric material. Additionally, an adhesive bond strength of the first surface of the polymeric material to the applied area of the patient is less than the cohesive strength of the polymeric material so that upon removal of the reservoir assembly of the invention from the applied area of the patient, substantially no polymeric material remains on the applied area and the hydrophilic reservoir remains substantially intact and adhesively adherent to the electrode.

Abstract translation: 用于离子电渗药物递送装置的本发明的储存器电极组件包括位于与电极导电关系的电极和亲水性储存器。 亲水性储存器由具有粘附到电极的第一表面和第二表面的吸水性亲水性交联聚合物材料形成。 当应用于患者皮肤区域时，聚合物材料的第一表面可剥离地粘附。 聚合物材料具有内聚强度，其形成粘合剂粘合，聚合物材料的第二表面与电极之间的粘合强度大于聚合物材料的内聚强度。 此外，聚合物材料的第一表面与患者的施用区域的粘合粘合强度小于聚合材料的内聚强度，使得当从患者的施用区域移除本发明的储器组件时， 基本上没有聚合物材料保留在施加的区域上，并且亲水性储存器保持基本上完整且粘附到电极上。